Filing Details
- Accession Number:
- 0000884905-15-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 16:47:21
- Reporting Period:
- 2015-02-27
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 16:47:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884905 | Praxair Inc | PX | Industrial Inorganic Chemicals (2810) | 061249050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190775 | F Stephen Angel | C/O Praxair, Inc. 39 Old Ridgebury Road Danbury CT 06810-5113 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-27 | 40,786 | $53.98 | 142,096 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-27 | 40,786 | $128.19 | 101,310 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-03-02 | 16,242 | $53.98 | 117,552 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-02 | 16,242 | $129.20 | 101,310 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-03-02 | 125,000 | $61.47 | 226,310 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-02 | 125,000 | $129.38 | 101,310 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-02-27 | 40,786 | $0.00 | 40,786 | $53.98 |
Common Stock | Stock Option (right t buy) | Disposition | 2015-03-02 | 16,242 | $0.00 | 16,242 | $53.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-03-02 | 125,000 | $0.00 | 125,000 | $61.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,242 | 2007-02-28 | 2016-02-29 | No | 4 | M | Direct |
0 | 2007-02-28 | 2016-02-29 | No | 4 | M | Direct |
183,300 | 2008-02-27 | 2017-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,268 | Indirect | In trust for children |
Common Stock | 58,065 | Indirect | Grantor Retained Annuity Trusts |
Common Stock | 7,879 | Indirect | 401(k) |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $83.89 | 2009-02-26 | 2018-02-26 | 195,200 | 195,200 | Direct |
Common Stock | Stock Option (right to buy) | $60.92 | 2010-02-24 | 2019-02-24 | 281,510 | 281,510 | Direct |
Common Stock | Stock Option (right to buy) | $76.16 | 2011-02-23 | 2020-02-23 | 204,640 | 204,640 | Direct |
Common Stock | Stock Option (right to buy) | $97.84 | 2012-02-22 | 2021-02-22 | 218,175 | 218,175 | Direct |
Common Stock | Stock Option (right to buy) | $109.68 | 2013-02-28 | 2022-02-28 | 236,510 | 236,510 | Direct |
Common Stock | Stock Option (right to buy) | $110.58 | 2014-02-26 | 2023-02-26 | 187,015 | 187,015 | Direct |
Common Stock | Stock Option (right to buy) | $128.80 | 2015-02-25 | 2024-02-25 | 203,930 | 203,930 | Direct |
Common Stock | Stock Option (right to buy) | $128.38 | 2016-02-24 | 2025-02-24 | 261,075 | 261,075 | Direct |
Common Stock | Deferred Stock Unit | $0.00 | 61,187 | 61,187 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-02-26 | 195,200 | 195,200 | Direct |
2019-02-24 | 281,510 | 281,510 | Direct |
2020-02-23 | 204,640 | 204,640 | Direct |
2021-02-22 | 218,175 | 218,175 | Direct |
2022-02-28 | 236,510 | 236,510 | Direct |
2023-02-26 | 187,015 | 187,015 | Direct |
2024-02-25 | 203,930 | 203,930 | Direct |
2025-02-24 | 261,075 | 261,075 | Direct |
61,187 | 61,187 | Direct |
Footnotes
- The $128.19 price reported is the weighted average sale price. The sale prices ranged from $128.000 to $128.620 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- The $129.20 price reported is the weighted average sale price. The sale prices ranged from $129.050 to $129.310 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- The $129.38 price reported is the weighted average sale price. The sale prices ranged from $129.045 to $130.37 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
- This option vests over three years in three consecutive equal annual installments beginning on February 24, 2016.
- Conversion to Praxair Common Stock is on a 1-for-1 basis.
- Deferred stock units acquired under the Praxair Compensation Deferral Program as amended and are to be settled in Praxair Common Stock.